Koch CJ - Search Results

1

Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles.

Koch CJ, Hahn SM, Rockwell K Jr, Covey JM, McKenna WG, Evans SM. Koch CJ, et al. Cancer Chemother Pharmacol. 2001 Sep;48(3):177-87. doi: 10.1007/s002800100324. Cancer Chemother Pharmacol. 2001. PMID: 11592338 Clinical Trial.

2

2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.

Evans SM, Jenkins WT, Joiner B, Lord EM, Koch CJ. Evans SM, et al. Among authors: koch cj. Cancer Res. 1996 Jan 15;56(2):405-11. Cancer Res. 1996. PMID: 8542599

3

Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors.

Laughlin KM, Evans SM, Jenkins WT, Tracy M, Chan CY, Lord EM, Koch CJ. Laughlin KM, et al. Among authors: koch cj. J Pharmacol Exp Ther. 1996 May;277(2):1049-57. J Pharmacol Exp Ther. 1996. PMID: 8627516

4

Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: comparative measurements using EF5 binding and the Eppendorf needle electrode.

Jenkins WT, Evans SM, Koch CJ. Jenkins WT, et al. Among authors: koch cj. Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):1005-17. doi: 10.1016/s0360-3016(99)00342-9. Int J Radiat Oncol Biol Phys. 2000. PMID: 10705024 Free article.

5

Detection of hypoxia in human squamous cell carcinoma by EF5 binding.

Evans SM, Hahn S, Pook DR, Jenkins WT, Chalian AA, Zhang P, Stevens C, Weber R, Weinstein G, Benjamin I, Mirza N, Morgan M, Rubin S, McKenna WG, Lord EM, Koch CJ. Evans SM, et al. Among authors: koch cj. Cancer Res. 2000 Apr 1;60(7):2018-24. Cancer Res. 2000. PMID: 10766193 Clinical Trial.

6

Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide ].

Busch TM, Hahn SM, Evans SM, Koch CJ. Busch TM, et al. Among authors: koch cj. Cancer Res. 2000 May 15;60(10):2636-42. Cancer Res. 2000. PMID: 10825135

7

Hypoxia in human intraperitoneal and extremity sarcomas.

Evans SM, Hahn SM, Magarelli DP, Zhang PJ, Jenkins WT, Fraker DL, Hsi RA, McKenna WG, Koch CJ. Evans SM, et al. Among authors: koch cj. Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):587-96. doi: 10.1016/s0360-3016(00)01494-2. Int J Radiat Oncol Biol Phys. 2001. PMID: 11173159 Clinical Trial.

8

Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation.

Evans SM, Hahn SM, Magarelli DP, Koch CJ. Evans SM, et al. Among authors: koch cj. Am J Clin Oncol. 2001 Oct;24(5):467-72. doi: 10.1097/00000421-200110000-00011. Am J Clin Oncol. 2001. PMID: 11586098

9

Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity.

Koch CJ, Evans SM, Lord EM. Koch CJ, et al. Br J Cancer. 1995 Oct;72(4):869-74. doi: 10.1038/bjc.1995.426. Br J Cancer. 1995. PMID: 7547233 Free PMC article.

10

Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide].

Evans SM, Joiner B, Jenkins WT, Laughlin KM, Lord EM, Koch CJ. Evans SM, et al. Among authors: koch cj. Br J Cancer. 1995 Oct;72(4):875-82. doi: 10.1038/bjc.1995.427. Br J Cancer. 1995. PMID: 7547234 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

222 results

Search Page